• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT SOLO VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT SOLO VASCULAR STENT SYSTEM Back to Search Results
Model Number EX062003CL
Device Problem Obstruction of Flow (2423)
Patient Problem Stenosis (2263)
Event Date 10/23/2018
Event Type  Injury  
Manufacturer Narrative
No medical images have been made available to the manufacturer.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.Medical records review: the patient with history of dry gangrene and total occlusion of the right superficial femoral artery was scheduled for vascular intervention.Two stents were placed and there was no reported complication.Approximately one week post hospital admission, the patient was right critical limb ischemia required amputation.The right common femoral artery was accessed and an arteriography demonstrated 4cm occlusion of the left superficial femoral artery.The decision was made to place a stent in the left superficial femoral artery prior to right below the knee amputation.Hemostasis was achieved and the patient was transported in stable condition.(08/2018).
 
Event Description
It was reported through the results of a clinical trial, that approximately one month post angioplasty procedure in the distal superficial femoral artery (sfa) with a focused force percutaneous transluminal angioplasty (pta) balloon, the patient had two vascular stents placed in the right sfa for total occlusion.Approximately one week post vascular stent placement, the patient underwent right below the knee amputation due to dry gangrene and critical limb ischemia.The vascular stents were stenosed at the time of the amputation.The current patient status was not provided.
 
Event Description
It was reported through the results of a clinical trial, that approximately one month post angioplasty procedure in the distal superficial femoral artery (sfa) with a focused force percutaneous transluminal angioplasty (pta) balloon, the patient had two vascular stents placed in the right sfa for total occlusion.Approximately one week post vascular stent placement, the patient underwent right below the knee amputation due to dry gangrene and critical limb ischemia.The vascular stents were stenosed at the time of the amputation.The current patient status was not provided.
 
Manufacturer Narrative
Manufacturing review: the lot records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.The review shows that no remarkable incidents occurred during the manufacturing process.No relevant manufacturing process changes were implemented, that could have led to the event reported.Investigation summary: as no x-ray images were provided the reported in stent restenosis could not be verified.An alleged device relation could not be determined.Based on the information available the investigation will be completed with inconclusive result.Based on the information available a definite root cause for the event reported could not be identified.Labeling review: in reviewing the current version of the labeling supplied with this product, it was found that the ifu sufficiently addresses the potential risk.The ifu states that 'arterial occlusion/restenosis of the treated vessel' as well as 'amputation' are potential adverse events that may occur.Based on the ifu predilation of the lesion should be performed using standard techniques; post stent expansion with a pta catheter is recommended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT SOLO VASCULAR STENT SYSTEM
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key8200872
MDR Text Key131585160
Report Number9681442-2018-00223
Device Sequence Number1
Product Code NIP
UDI-Device Identifier04049519004303
UDI-Public(01)04049519004303
Combination Product (y/n)N
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,study
Type of Report Initial,Followup
Report Date 02/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/17/2020
Device Model NumberEX062003CL
Device Catalogue NumberEX062003CL
Device Lot NumberANCV2551
Was Device Available for Evaluation? No
Date Manufacturer Received01/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age73 YR
Patient Weight58
-
-